Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
16,970,149
-
Share change
-
+16,970,149
-
Total reported value
-
$236,408,000
-
Price per share
-
$13.97
-
Number of holders
-
29
-
Value change
-
+$236,408,000
-
Number of buys
-
29
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q2 2017
As of 30 Jun 2017,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,970,149 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Rock Springs Capital Management LP, ProQuest Associates IV LLC, RHO CAPITAL PARTNERS INC, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, SCOPIA CAPITAL MANAGEMENT LP, and Alyeska Investment Group, L.P..
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.